Lipid Profile Among Patients with Acute Myocardial Infarction in Iraq: A Cross-Sectional Study

Authors

  • Rebar Abdullah Community Health and Psychiatric Nursing Department, College of Nursing, University of Duhok, Kurdistan Region, Iraq.
  • Diana Mhammedsadiq Duhok Directory of Health, Kurdistan Region, Iraq.
  • Jailan Mohammedsalih Duhok Directory of Health, Kurdistan Region, Iraq.
  • Alan Abdullah Basic Sciences Department, College of Nursing, University of Duhok, Kurdistan Region, Iraq.

DOI:

https://doi.org/10.51152/jbarbiomed.v12i1.260

Keywords:

Lipid profile, Acute myocardial infarction, Dyslipidemia, Cardiovascular disease, Coronary artery diseases

Abstract

Background: Cardiovascular diseases are the global leading cause of morbidity and mortality, with acute myocardial infarction (AMI) being a major clinical manifestation. Dyslipidemia is a modifiable risk factor for atherosclerosis and coronary diseases.

Objectives: This study aimed to assess lipid profiles among AMI patients in Duhok City, Iraq.

Methods: A cross-sectional study was carried out at Azadi Teaching Hospital and Cardiac Center in Duhok City from June to November 2025. A convenient sample of 80 AMI patients aged ≥18 years was included. Sociodemographic and clinical data were collected through interviews and medical records. Blood samples were analyzed for total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG). Data were analyzed using SPSS version 23, with p < 0.05 considered statistically significant.

Results: The mean age of patients was 53.0 ± 14.07 years, and 65.1% were aged ≥50 years. AMI was more common among males, urban residents, and individuals with low to moderate socioeconomic status. The lipid profile showed an atherogenic pattern, with elevated triglycerides (212.93 ± 71.91 mg/dL), total cholesterol (210.0 ± 51.68 mg/dL), and LDL-C (125.1 ± 41.24 mg/dL), along with reduced HDL-C levels (39.55 ± 11.51 mg/dL).

Conclusion: Dyslipidemia is highly prevalent among AMI patients in Duhok, characterized by elevated atherogenic lipids and low HDL-C. Early screening and lipid-lowering interventions are recommended to reduce cardiovascular risk.

References

Abera, A., Worede, A., Hirigo, A. T., Alemayehu, R., & Ambachew, S. (2024). Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study. European Journal of Medical Research, 29(1), 237. https://doi.org/10.1186/s40001-024-01802-x

Ahmed, T., Nath, A., Jahan, N., Khadka, A., Kishore, J., Farokhrouz, A., & Bowden, R. G. (2025). Socioeconomic Disparities and Other Factors in Dyslipidemia: Insights from NHANES 2017–2020 Data. International Journal of Translational Medicine, 5(2), 18. https://doi.org/10.3390/ijtm5020018

Albrektsen, G., Heuch, I., Løchen, M.-L., Thelle, D. S., Wilsgaard, T., Njølstad, I., & Bønaa, K. H. (2016). Lifelong gender gap in risk of incident myocardial infarction: The Tromsø study: The Tromsø study. JAMA Internal Medicine, 176(11), 1673–1679. https://doi.org/10.1001/jamainternmed.2016.5451

Alhabib, K. F., Kinsara, A. J., Alghamdi, S., Al-Murayeh, M., Hussein, G. A., AlSaif, S., Khalaf, H., Alfaleh, H., Hersi, A., Kashour, T., Al-Saleh, A., Ali, M., Ullah, A., Mhish, H., Abdo, A. N., Almutairi, F., Arafah, M. R., AlKutshan, R., Aldosari, M., … AlHarbi, I. A. (2019). The first survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and long-term outcomes (STARS-1 Program). PloS One, 14(5), e0216551. https://doi.org/10.1371/journal.pone.0216551

Allami, M. (2024). Epidemiology of acute coronary syndrome in Northern Iraq. Cureus, 16(6), e63291. https://doi.org/10.7759/cureus.63291

Alpert, J. S., Thygesen, K., Antman, E., & Bassand, J. P. (2000). Myocardial infarction redefined—A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee. Journal of the American College of Cardiology, 36, 959–969. https://doi.org/10.1016/S0735-1097(00)00804-4

Aubiniere-Robb, L., Dickerson, J. E., & Brady, A. J. B. (2019). Lipid testing after myocardial infarction. British Journal of Cardiology. https://doi.org/10.5837/bjc.2019.041

Ballena-Caicedo, J., Zuzunaga-Montoya, F. E., Loayza-Castro, J. A., Vásquez-Romero, L. E. M., Tapia-Limonchi, R., De Carrillo, C. I. G., & Vera-Ponce, V. J. (2025). Global prevalence of dyslipidemias in the general adult population: A systematic review and meta-analysis. Journal of Health, Population and Nutrition, 44(1), 308. https://doi.org/10.1186/s41043-025-01054-3

Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., Delling, F. N., Djousse, L., Elkind, M. S. V., Ferguson, J. F., Fornage, M., Jordan, L. C., Khan, S. S., Kissela, B. M., Knutson, K. L., … American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. (2019). Heart disease and stroke statistics-2019 update: A report from the American heart association. Circulation, 139(10), e56–e528. https://doi.org/10.1161/CIR.0000000000000659

Brunner, E. J., Chandola, T., & Marmot, M. G. (2017). Social inequality in CHD. Social Science & Medicine, 188, 56–63. https://doi.org/10.1016/j.socscimed.2017.07.011

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., et al. (2020). 2019 ESC/EAS guidelines for the management of dyslipidaemias. European Heart Journal, 41(1), 111–188. https://doi.org/10.1093/eurheartj/ehz455

Cholesterol Treatment Trialists’ Collaboration. (2019). Efficacy and safety of statin therapy in older people. The Lancet, 393(10170), 407–415. https://doi.org/10.1016/S0140-6736(18)31942-1

Costantino, S., Paneni, F., & Cosentino, F. (2016). Ageing and cardiovascular disease. Journal of Physiology, 594(8), 2061–2073. https://doi.org/10.1113/JP270538

Curtis, A. B., Karki, R., Hattoum, A., & Sharma, U. C. (2018). Arrhythmias in ≥80 years. Journal of the American College of Cardiology, 71, 2041–2057. https://doi.org/10.1016/j.jacc.2018.03.019

de Groot, R., van den Hurk, K., Schoonmade, L. J., de Kort, W. L. A. M., Brug, J., & Lakerveld, J. (2019). Urban-rural differences in the association between blood lipids and characteristics of the built environment: a systematic review and meta-analysis. BMJ Global Health, 4(1), e001017. https://doi.org/10.1136/bmjgh-2018-001017

Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., Watts, G. F., Borén, J., Fazio, S., Horton, J. D., Masana, L., Nicholls, S. J., Nordestgaard, B. G., van de Sluis, B., Taskinen, M. R., Tokgözoglu, L., … Catapano, A. L. (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European heart journal, 38(32), 2459–2472. https://doi.org/10.1093/eurheartj/ehx144

Garcia, M., Mulvagh, S. L., Merz, C. N., Buring, J. E., & Manson, J. E. (2016). Cardiovascular disease in women. Circulation Research, 118, 1273–1293. https://doi.org/10.1161/CIRCRESAHA.116.307547

Guijarro, C., & Cosin-Sales, J. (2021). LDL cholesterol and atherosclerosis. Clinical Investigation in Arteriosclerosis, 33(Suppl 1), 25–32. https://doi.org/10.1016/j.arteri.2020.12.004

Jain, R., Sharma, A., & Gupta, A. (2017). Lipid profile changes in acute MI. Journal of Clinical and Diagnostic Research, 11(5), BC01–BC04. https://doi.org/10.7860/JCDR/2017/25567.9813

Kelli, H. M., Mehta, A., Tahhan, A. S., Liu, C., Kim, J. H., Dong, T. A., Dhindsa, D. S., Ghazzal, B., Choudhary, M. K., Sandesara, P. B., Hayek, S. S., Topel, M. L., Alkhoder, A. A., Martini, M. A., Sidoti, A., Ko, Y.-A., Lewis, T. T., Vaccarino, V., Sperling, L. S., & Quyyumi, A. A. (2019). Low educational attainment is a predictor of adverse outcomes in patients with coronary artery disease. Journal of the American Heart Association, 8(17). https://doi.org/10.1161/jaha.119.013165

Dienhart, C., Paulweber, B., Frey, V. N., Iglseder, B., Trinka, E., Langthaler, P., Aigner, E., Granitz, M., & Wernly, B. (2023). Inverse Association between Educational Status and Coronary CT Calcium Scores: Should We Reflect This in Our ASCVD Risk Assumptions? International Journal of Environmental Research and Public Health, 20(12), 6065. https://doi.org/10.3390/ijerph20126065

Khan, H. A., Alhomida, A. S., & Sobki, S. H. (2013). Lipid profile of patients with acute myocardial infarction. Biomarker Insights, 8, 1–7. https://doi.org/10.4137/BMI.S11015

Kosmas, C. E., Rodriguez-Polanco, S., Bousvarou, M. D., Papakonstantinou, E. J., Peña-Genao, E., Guzman, E., & Kostara, C. E. (2023). TG/HDL-C ratio as a risk marker. Diagnostics, 13(5), 929. https://doi.org/10.3390/diagnostics13050929

Kumar, A. S., & Sinha, N. (2020). Cardiovascular disease in India: A 360-degree overview. Medical Journal Armed Forces India, 76(1), 1. https://doi.org/10.1016/j.mjafi.2019.12.005

Libby, P. (2021). The changing landscape of atherosclerosis. Nature, 592, 524–533. https://doi.org/10.1038/s41586-021-03392-8

Libby, P., Buring, J. E., Badimon, L., Hansson, G. K., Deanfield, J., Bittencourt, M. S., Tokgözoğlu, L., & Lewis, E. F. (2019). Atherosclerosis. Nature reviews. Disease primers, 5(1), 56. https://doi.org/10.1038/s41572-019-0106-z

Libby, P., Ridker, P. M., & Hansson, G. K. (2009). Inflammation in atherosclerosis. Journal of the American College of Cardiology, 54(23), 2129–2138. https://doi.org/10.1016/j.jacc.2009.09.009

Maas, A. H. E. M., & Appelman, Y. E. A. (2010). Gender differences in coronary heart disease. Netherlands Heart Journal, 18(12), 598–603. https://doi.org/10.1007/s12471-010-0841-y

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., Graham, I. M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T. R., Riccardi, G., Richter, D. J., Sabatine, M. S., Taskinen, M. R., Tokgozoglu, L., … ESC Scientific Document Group (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European heart journal, 41(1), 111–188. https://doi.org/10.1093/eurheartj/ehz455

Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2017). Extreme high HDL cholesterol and mortality. European Heart Journal, 38(32), 2478–2486. https://doi.org/10.1093/eurheartj/ehx163

Mechanic, O. J., Gavin, M., & Grossman, S. A. (2023). Acute myocardial infarction. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459269/

Mohammad, A. M., Rashad, H. H., Habeeb, Q. S., Rashad, B. H., & Saeed, S. Y. (2021). Coronary artery disease in Kurdistan region. American Journal of Cardiovascular Disease, 11(1), 39–45.

Pana, T. A., Mamas, M. A., Wareham, N. J., Khaw, K.-T., Dawson, D. K., & Myint, P. K. (2024). Sex-specific lifetime risk of cardiovascular events: the European Prospective Investigation into Cancer-Norfolk prospective population cohort study. European Journal of Preventive Cardiology, 31(2), 230–241. https://doi.org/10.1093/eurjpc/zwad283

Pappan, N., Awosika, A. O., & Rehman, A. (2024). Dyslipidemia. In StatPearls. StatPearls Publishing.

Pirillo, A., Casula, M., Olmastroni, E., Norata, G. D., & Catapano, A. L. (2021). Global epidemiology of dyslipidaemias. Nature Reviews. Cardiology, 18(10), 689–700. https://doi.org/10.1038/s41569-021-00541-4

Pitt, B., Loscalzo, J., Ycas, J., & Raichlen, J. S. (2008). Lipid levels after acute coronary syndromes. Journal of the American College of Cardiology, 51(15), 1440–1445. https://doi.org/10.1016/j.jacc.2007.11.075

Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., Davis, L. L., de Lemos, J. A., DeWald, T. A., Elgendy, I. Y., Feldman, D. N., Goyal, A., Isiadinso, I., Menon, V., Morrow, D. A., Williams, M. S. (2025). 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the Management of Patients With Acute Coronary Syndromes: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation, 151(13), e771–e862. https://doi.org/10.1161/CIR.0000000000001309

EUGenMed Cardiovascular Clinical Study Group, Regitz-Zagrosek, V., Oertelt-Prigione, S., Prescott, E., Franconi, F., Gerdts, E., Foryst-Ludwig, A., Maas, A. H. E. M., Kautzky-Willer, A., Knappe-Wegner, D., Kintscher, U., Ladwig, K. H., Schenck-Gustafsson, K., & Stangl, V. (2016). Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. European Heart Journal, 37(1), 24–34. https://doi.org/10.1093/eurheartj/ehv598

Ridker, P. M. (2014). LDL cholesterol: Controversies and future therapeutic directions. The Lancet, 384(9943), 607–617. https://doi.org/10.1016/S0140-6736(14)61009-6

Rosengren, A., Smyth, A., Rangarajan, S., Ramasundarahettige, C., Bangdiwala, S. I., AlHabib, K. F., Avezum, A., Bengtsson Boström, K., Chifamba, J., Gulec, S., Gupta, R., Igumbor, E. U., Iqbal, R., Ismail, N., Joseph, P., Kaur, M., Khatib, R., Kruger, I. M., Lamelas, P., … Yusuf, S. (2019). Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. The Lancet. Global Health, 7(6), e748–e760. https://doi.org/10.1016/S2214-109X(19)30045-2

Schultz, W. M., Kelli, H. M., Lisko, J. C., Varghese, T., Shen, J., Sandesara, P., Quyyumi, A. A., Taylor, H. A., Gulati, M., Harold, J. G., Mieres, J. H., Ferdinand, K. C., Mensah, G. A., & Sperling, L. S. (2018). Socioeconomic status and cardiovascular outcomes: Challenges and interventions: Challenges and interventions. Circulation, 137(20), 2166–2178. https://doi.org/10.1161/CIRCULATIONAHA.117.029652

Shohaimi, S., Boekholdt, M. S., Luben, R., Wareham, N. J., & Khaw, K.-T. (2014). Distribution of lipid parameters according to different socio-economic indicators- the EPIC-Norfolk prospective population study. BMC Public Health, 14(1), 782. https://doi.org/10.1186/1471-2458-14-782

Steptoe, A., & Kivimäki, M. (2013). Stress and cardiovascular disease. Annual Review of Public Health, 34, 337–354. https://doi.org/10.1146/annurev-publhealth-031912-114452

Stringhini, S., Carmeli, C., Jokela, M., Avendaño, M., Muennig, P., Guida, F., Ricceri, F., d'Errico, A., Barros, H., Bochud, M., Chadeau-Hyam, M., Clavel-Chapelon, F., Costa, G., Delpierre, C., Fraga, S., Goldberg, M., Giles, G. G., Krogh, V., Kelly-Irving, M., Layte, R., … LIFEPATH consortium (2017). Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and women. Lancet (London, England), 389(10075), 1229–1237. https://doi.org/10.1016/S0140-6736(16)32380-7

Suman, S., Pravalika, J., Manjula, P., & Farooq, U. (2023). Gender and CVD- does it really matters? Current Problems in Cardiology, 48(5), 101604. https://doi.org/10.1016/j.cpcardiol.2023.101604

Sztaniszlav, A., Bjorkenheim, A., Magnusson, A., Edvardsson, N., & Poci, D. (2024). Education level and the incidence of heart failure, acute myocardial infarction, and stroke in patients with atrial fibrillation. European Heart Journal, 45(Supplement_1). https://doi.org/10.1093/eurheartj/ehae666.3634

Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., White, H. D., & Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction (2018). Fourth Universal Definition of Myocardial Infarction (2018). Circulation, 138(20), e618–e651. https://doi.org/10.1161/CIR.0000000000000617

Vaccarino, V., Badimon, L., Corti, R., de Wit, C., Dorobantu, M., Hall, A., Koller, A., Marzilli, M., Pries, A., Bugiardini, R., & Working Group on Coronary Pathophysiology and Microcirculation. (2011). Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovascular Research, 90(1), 9–17. https://doi.org/10.1093/cvr/cvq394

World Health Organization. (2023). Cardiovascular diseases (CVDs). Retrieved November 26, 2025, from https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

World Health Organization. (2025a). Cardiovascular diseases. Retrieved October 12, 2025, from https://www.who.int/health-topics/cardiovascular-diseases

World Health Organization. (2025b). Noncommunicable diseases. Retrieved November 26, 2025, from https://www.emro.who.int/iraq/priority-areas/noncommunicable-diseases.html

Zuo, J., Wang, P., Xue, K., Tan, Y., Zhang, T., Li, Y., He, F., Wu, W., Yan, Z., Cong, L., & Li, G. (2025). Lipid alterations in acute myocardial infarction are associated with gut microbiota. Microbiology spectrum, 13(4), e0237024. https://doi.org/10.1128/spectrum.02370-2.

Downloads

Published

2026-05-02

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

How to Cite

Lipid Profile Among Patients with Acute Myocardial Infarction in Iraq: A Cross-Sectional Study. (2026). Journal of Basic and Applied Research in Biomedicine, 12(1), 7-15. https://doi.org/10.51152/jbarbiomed.v12i1.260

Similar Articles

51-51 of 51

You may also start an advanced similarity search for this article.